Login / Signup

New Actors Driving the Epithelial-Mesenchymal Transition in Cancer: The Role of Leptin.

Monserrat Olea-FloresJuan C Juárez-CruzMiriam Daniela Zuñiga-EulogioErika AcostaEduardo García-RodríguezAna E Zacapala-GomezMiguel Angel Mendoza-CatalánJulio Ortiz-OrtizCarlos Ortuño-PinedaNapoleón Navarro-Tito
Published in: Biomolecules (2020)
Leptin is a hormone secreted mainly by adipocytes; physiologically, it participates in the control of appetite and energy expenditure. However, it has also been linked to tumor progression in different epithelial cancers. In this review, we describe the effect of leptin on epithelial-mesenchymal transition (EMT) markers in different study models, including in vitro, in vivo, and patient studies and in various types of cancer, including breast, prostate, lung, and ovarian cancer. The different studies report that leptin promotes the expression of mesenchymal markers and a decrease in epithelial markers, in addition to promoting EMT-related processes such as cell migration and invasion and poor prognosis in patients with cancer. Finally, we report that leptin has the greatest biological relevance in EMT and tumor progression in breast, lung, prostate, esophageal, and ovarian cancer. This relationship could be due to the key role played by the enriched tumor microenvironment in adipose tissue. Together, these findings demonstrate that leptin is a key biomolecule that drives EMT and metastasis in cancer.
Keyphrases